Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Priming in Elderly AML and Advanced MDS
NCT00199147Phase 4Unknown
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Jan 2000
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Universitätsklinikum Frankfurt. Status: unknown.
02
Drugs
filgrastim
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00199147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199147.